Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic-Reference-Cited by-同舟云学术

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic

Published:2023-09 Issue:5 Volume:78 Page:523-529
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Grandvuillemin Aurélie,Rocher Fanny,Valnet-Rabier Marie Blanche,Drici Milou-Daniel,Dautriche Anne

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference20 articles.

1. HCSP. Avis relatif à la prise en charge des cas confirmés d’infection au virus SARS-CoV2. 5 mars 2020. https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=771.[Accessed 9 January 2023].

2. French pharmacovigilance Network. French pharmacovigilance Network. French pharmacovigilance public system and COVID-19 pandemic;Grandvuillemin;Drug Saf,2021

3. ANSM. Suivi des effets indésirables des médicaments utilisés dans la prise en charge du COVID-19. 2022. http://ansm.sante.fr/dossiers-thematiques/covid-19-dispositif-renforce-de-pharmacovigilance-et-daddictovigilance. [Accessed 9 January 2023].

4. Causality assessment in pharmacovigilance: the French method and its successive updates;Miremont-Salamé;Therapie,2016

5. Pharmacovigilance and drug safety: fair prescribing and clinical research;Montastruc;Therapie,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Factors and Pathways of Hepatotoxicity Associated with HIV/SARS-CoV-2 Protease Inhibitors;International Journal of Molecular Sciences;2023-04-27

2. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms;Vaccines;2023-02-10